Article
GLP-1-mediated gene therapy approaches for diabetes treatment
1 Jan 2014
Abstract excerpt
Glucagon-like peptide (GLP)-1 is an incretin hormone with several antidiabetic functions including stimulation of glucose-dependent insulin secretion, increase in insulin gene expression and beta-cell survival. Despite the initial technical difficulties and profound inefficiency of direct gene transfer into the pancreas that seriously restricted in vivo gene transfer experiments with GLP-1, recent exploitation of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
